• Wed. May 29th, 2024

Adaptive Biotechnologies Corporation: Revolutionizing Disease Diagnosis and Treatment with its Immune Medicine Platform

BySamantha Jones

Mar 27, 2024
Adaptive Biotechnologies Announces Business Update Conference Call and Webcast Set for April 2, 2024

Adaptive Biotechnologies Corporation, listed on Nasdaq as ADPT, is a biotechnology company based in Seattle. The company focuses on translating the genetics of the adaptive immune system into clinical products for diagnosing and treating diseases. They recently announced that they will be hosting a business update conference call and webcast on April 2, 2024, after the market closes. The event will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time and will be accessible through the “Investors” section of their website at www.adaptivebiotech.com. The webcast will also be archived for replay within 24 hours.

Adaptive Biotechnologies believes that the adaptive immune system can be a powerful tool for diagnosing and treating diseases, but its complexity has limited its full utilization. Their immune medicine platform aims to decode and leverage the genetics of the adaptive immune system with scale, precision, and speed. The company collaborates with biopharmaceutical companies, informs drug development, and develops clinical diagnostics in two main areas: Minimal Residual Disease (MRD) and Immune Medicine. Their products and clinical pipeline focus on diagnosing, monitoring, and treating diseases like cancer, autoimmune disorders, and infectious diseases, with the goal of creating personalized immune-driven clinical products for each patient.

For investors interested in Adaptive Biotechnologies, the company’s Vice President of Investor Relations, Karina Calzadilla, can be reached at 201-396-1687 or investors@adaptivebiotech.com

By Samantha Jones

As a content writer at newsnnk.com, I weave words into captivating stories that inform and engage our readers. With a passion for storytelling and an eye for detail, I strive to deliver high-quality and engaging content that resonates with our audience. From breaking news to thought-provoking features, I am dedicated to providing informative and compelling articles that keep our readers informed and entertained. Join me on this journey as we explore the world through the power of words.

Leave a Reply